Novel Small Molecule Inhibitors That Prevent the Neuroparalysis of Tetanus Neurotoxin

Tetanus neurotoxin (TeNT) is a protein exotoxin produced by <i>Clostridium tetani</i> that causes the deadly spastic neuroparalysis of tetanus. It consists of a metalloprotease light chain and of a heavy chain linked via a disulphide bond. TeNT binds to the neuromuscular junction (NMJ) a...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Giulia Zanetti, Andrea Mattarei, Florigio Lista, Ornella Rossetto, Cesare Montecucco, Marco Pirazzini
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
EGA
R
Acceso en línea:https://doaj.org/article/63b35b43dab140a88f7cfa13188faf6a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:63b35b43dab140a88f7cfa13188faf6a
record_format dspace
spelling oai:doaj.org-article:63b35b43dab140a88f7cfa13188faf6a2021-11-25T18:39:36ZNovel Small Molecule Inhibitors That Prevent the Neuroparalysis of Tetanus Neurotoxin10.3390/ph141111341424-8247https://doaj.org/article/63b35b43dab140a88f7cfa13188faf6a2021-11-01T00:00:00Zhttps://www.mdpi.com/1424-8247/14/11/1134https://doaj.org/toc/1424-8247Tetanus neurotoxin (TeNT) is a protein exotoxin produced by <i>Clostridium tetani</i> that causes the deadly spastic neuroparalysis of tetanus. It consists of a metalloprotease light chain and of a heavy chain linked via a disulphide bond. TeNT binds to the neuromuscular junction (NMJ) and it is retro-axonally transported into vesicular compartments to the spinal cord, where it is released and taken up by inhibitory interneuron. Therein, the catalytic subunit is translocated into the cytoplasm where it cleaves its target protein VAMP-1/2 with consequent blockage of the release of inhibitory neurotransmitters. Vaccination with formaldehyde inactivated TeNT prevents the disease, but tetanus is still present in countries where vaccination coverage is partial. Here, we show that small molecule inhibitors interfering with TeNT trafficking or with the reduction of the interchain disulphide bond block the activity of the toxin in neuronal cultures and attenuate tetanus symptoms in vivo. These findings are relevant for the development of therapeutics against tetanus based on the inhibition of toxin molecules that are being retro-transported to or are already within the spinal cord and are, thus, not accessible to anti-TeNT immunoglobulins.Giulia ZanettiAndrea MattareiFlorigio ListaOrnella RossettoCesare MontecuccoMarco PirazziniMDPI AGarticletetanus neurotoxintraffickingdisulfide reductionthioredoxin system inhibitorsEGAMedicineRPharmacy and materia medicaRS1-441ENPharmaceuticals, Vol 14, Iss 1134, p 1134 (2021)
institution DOAJ
collection DOAJ
language EN
topic tetanus neurotoxin
trafficking
disulfide reduction
thioredoxin system inhibitors
EGA
Medicine
R
Pharmacy and materia medica
RS1-441
spellingShingle tetanus neurotoxin
trafficking
disulfide reduction
thioredoxin system inhibitors
EGA
Medicine
R
Pharmacy and materia medica
RS1-441
Giulia Zanetti
Andrea Mattarei
Florigio Lista
Ornella Rossetto
Cesare Montecucco
Marco Pirazzini
Novel Small Molecule Inhibitors That Prevent the Neuroparalysis of Tetanus Neurotoxin
description Tetanus neurotoxin (TeNT) is a protein exotoxin produced by <i>Clostridium tetani</i> that causes the deadly spastic neuroparalysis of tetanus. It consists of a metalloprotease light chain and of a heavy chain linked via a disulphide bond. TeNT binds to the neuromuscular junction (NMJ) and it is retro-axonally transported into vesicular compartments to the spinal cord, where it is released and taken up by inhibitory interneuron. Therein, the catalytic subunit is translocated into the cytoplasm where it cleaves its target protein VAMP-1/2 with consequent blockage of the release of inhibitory neurotransmitters. Vaccination with formaldehyde inactivated TeNT prevents the disease, but tetanus is still present in countries where vaccination coverage is partial. Here, we show that small molecule inhibitors interfering with TeNT trafficking or with the reduction of the interchain disulphide bond block the activity of the toxin in neuronal cultures and attenuate tetanus symptoms in vivo. These findings are relevant for the development of therapeutics against tetanus based on the inhibition of toxin molecules that are being retro-transported to or are already within the spinal cord and are, thus, not accessible to anti-TeNT immunoglobulins.
format article
author Giulia Zanetti
Andrea Mattarei
Florigio Lista
Ornella Rossetto
Cesare Montecucco
Marco Pirazzini
author_facet Giulia Zanetti
Andrea Mattarei
Florigio Lista
Ornella Rossetto
Cesare Montecucco
Marco Pirazzini
author_sort Giulia Zanetti
title Novel Small Molecule Inhibitors That Prevent the Neuroparalysis of Tetanus Neurotoxin
title_short Novel Small Molecule Inhibitors That Prevent the Neuroparalysis of Tetanus Neurotoxin
title_full Novel Small Molecule Inhibitors That Prevent the Neuroparalysis of Tetanus Neurotoxin
title_fullStr Novel Small Molecule Inhibitors That Prevent the Neuroparalysis of Tetanus Neurotoxin
title_full_unstemmed Novel Small Molecule Inhibitors That Prevent the Neuroparalysis of Tetanus Neurotoxin
title_sort novel small molecule inhibitors that prevent the neuroparalysis of tetanus neurotoxin
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/63b35b43dab140a88f7cfa13188faf6a
work_keys_str_mv AT giuliazanetti novelsmallmoleculeinhibitorsthatpreventtheneuroparalysisoftetanusneurotoxin
AT andreamattarei novelsmallmoleculeinhibitorsthatpreventtheneuroparalysisoftetanusneurotoxin
AT florigiolista novelsmallmoleculeinhibitorsthatpreventtheneuroparalysisoftetanusneurotoxin
AT ornellarossetto novelsmallmoleculeinhibitorsthatpreventtheneuroparalysisoftetanusneurotoxin
AT cesaremontecucco novelsmallmoleculeinhibitorsthatpreventtheneuroparalysisoftetanusneurotoxin
AT marcopirazzini novelsmallmoleculeinhibitorsthatpreventtheneuroparalysisoftetanusneurotoxin
_version_ 1718410838362030080